Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
March 14, 2005
- GE Marketing Association Petitions for Revision of NHI Price System
March 7, 2005
- 1st 3 Qtrs Business Results
March 7, 2005
- JPMA Prepares "Implementation Manual" for Revised Charter
March 7, 2005
- BUSINESS FORECAST
March 7, 2005
- Domestic Pharma Firms Losing Employees: JPMA DATA BOOK 2005
March 7, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 7, 2005
- Sales of JCROA Member Firms Increase 22.6% in 2004
March 7, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 7, 2005
- Results of Survey on Ethical Drug Development Announced: Fuji-Keizai
March 7, 2005
- OTC Drug Industry Should Take Advantage of Booming Health Food Market: Mr Futagawa of MED
March 7, 2005
- BUSINESS NEWS IN BRIEF
March 7, 2005
- Experts Generally Agree on Risk Assessment Method for OTC Drugs
March 7, 2005
- PRESS SEMINAR
March 7, 2005
- OTC NEWS IN BRIEF
March 7, 2005
- Aiming for Sales of \100 Bil. in 2005: Mr Ohsawa of NBI
March 7, 2005
- DIAGNOSTIC NEWS IN BRIEF
March 7, 2005
- Korosho Submits Study Proposal on Use of Unapproved Drugs
March 7, 2005
- Eisai Establishes Marketing Subsidiary in Italy
March 7, 2005
- 5-Year Plan for New Basic Pharm. Research Institute Compiled
March 7, 2005
ページ
Japan’s pharmaceutical industry is undergoing a structural shift in its workforce, with the role of sales reps shrinking while production…
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…